Clinical Laserthermia Systems AB (publ) Cash Flow Conversion Efficiency
Clinical Laserthermia Systems AB (publ) cash flow conversion efficiency. Based on the latest financial reports, Clinical Laserthermia Systems AB (publ) (CLS-B) has a cash flow conversion efficiency ratio of -0.106x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-4.73 Million ≈ $-508.92K USD) by net assets (Skr44.50 Million ≈ $4.79 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Clinical Laserthermia Systems AB (publ) (2008–2025)
Cash flow conversion efficiency of Clinical Laserthermia Systems AB (publ) from 2008 to 2025. This chart illustrates how Clinical Laserthermia Systems AB (publ)'s cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for Clinical Laserthermia Systems AB (publ) for real-time trading data and today's change.
Clinical Laserthermia Systems AB (publ) Cash Flow Conversion Ratio Explained
Clinical Laserthermia Systems AB (publ) cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Clinical Laserthermia Systems AB (publ) Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Clinical Laserthermia Systems AB (publ) ranked by their cash flow conversion efficiency. Also see market cap of Clinical Laserthermia Systems AB (publ) for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Landmarks Bhd
KLSE:1643
|
-0.002x |
|
Baselode Energy Corp
V:FIND
|
-0.665x |
|
Siamraj Public Company Limited
BK:SR
|
0.026x |
|
Quhuo Limited
NASDAQ:QHUOD
|
N/A |
|
WALLBOX N.V. CL.A EO-12
F:67E
|
N/A |
|
BioLineRx Ltd
NASDAQ:BLRX
|
-0.196x |
|
Bhandari Hosiery Exports Limited
NSE:BHANDARI
|
0.015x |
|
SSH Group Ltd
AU:SSH
|
0.196x |
Annual Cash Flow Conversion Efficiency for Clinical Laserthermia Systems AB (publ) (2008–2025)
The table below shows the annual cash flow conversion efficiency of Clinical Laserthermia Systems AB (publ) from 2008 to 2025. Review Clinical Laserthermia Systems AB (publ) free cash flow efficiency to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Skr66.48 Million ≈ $7.15 Million |
Skr-33.20 Million ≈ $-3.57 Million |
-0.499x | +41.89% |
| 2024-12-31 | Skr65.69 Million ≈ $7.07 Million |
Skr-56.45 Million ≈ $-6.08 Million |
-0.859x | +43.70% |
| 2023-12-31 | Skr43.53 Million ≈ $4.68 Million |
Skr-66.45 Million ≈ $-7.15 Million |
-1.527x | +83.01% |
| 2022-12-31 | Skr7.87 Million ≈ $846.40K |
Skr-70.69 Million ≈ $-7.61 Million |
-8.988x | -187.72% |
| 2021-12-31 | Skr21.18 Million ≈ $2.28 Million |
Skr-66.17 Million ≈ $-7.12 Million |
-3.124x | +21.47% |
| 2020-12-31 | Skr13.93 Million ≈ $1.50 Million |
Skr-55.41 Million ≈ $-5.96 Million |
-3.978x | +28.85% |
| 2019-12-31 | Skr7.00 Million ≈ $752.99K |
Skr-39.12 Million ≈ $-4.21 Million |
-5.591x | -619.15% |
| 2018-12-31 | Skr49.81 Million ≈ $5.36 Million |
Skr-38.72 Million ≈ $-4.17 Million |
-0.777x | -5.20% |
| 2017-12-31 | Skr33.00 Million ≈ $3.55 Million |
Skr-24.39 Million ≈ $-2.62 Million |
-0.739x | +35.74% |
| 2016-12-31 | Skr17.06 Million ≈ $1.84 Million |
Skr-19.63 Million ≈ $-2.11 Million |
-1.150x | -19.85% |
| 2015-12-31 | Skr19.46 Million ≈ $2.09 Million |
Skr-18.68 Million ≈ $-2.01 Million |
-0.960x | -92.50% |
| 2014-12-31 | Skr31.58 Million ≈ $3.40 Million |
Skr-15.74 Million ≈ $-1.69 Million |
-0.499x | +28.93% |
| 2013-12-31 | Skr26.09 Million ≈ $2.81 Million |
Skr-18.30 Million ≈ $-1.97 Million |
-0.702x | +0.45% |
| 2012-12-31 | Skr17.09 Million ≈ $1.84 Million |
Skr-12.05 Million ≈ $-1.30 Million |
-0.705x | -28.07% |
| 2011-12-31 | Skr10.83 Million ≈ $1.17 Million |
Skr-5.96 Million ≈ $-641.36K |
-0.550x | -15.89% |
| 2010-12-31 | Skr10.36 Million ≈ $1.11 Million |
Skr-4.92 Million ≈ $-529.25K |
-0.475x | -38.16% |
| 2009-12-31 | Skr6.63 Million ≈ $713.34K |
Skr-2.28 Million ≈ $-245.16K |
-0.344x | -1723.94% |
| 2008-12-31 | Skr3.68 Million ≈ $395.79K |
Skr-69.30K ≈ $-7.46K |
-0.019x | -- |
About Clinical Laserthermia Systems AB (publ)
Clinical Laserthermia Systems AB (publ) engages in the development of treatment tools for diseased tissue under the TRANBERG brand in Sweden. It offers TRANBERG, a thermal therapy system designed to deliver laser energy to heat the target tissue. The company also provides mobile laser unit, a controlling component with a wavelength of 1064 nanometers that provides multiple options to control trea… Read more